Antibiotic susceptibilities of Yersinia enterocolitica recovered from children over a 12-year period

International Journal of Antimicrobial Agents

Volumn 27, Issue 5, 2006, Pages 449-452

  Abdel Haq, Nahed M ^a,b   Papadopol, Raluca ^b   Asmar, Basim I ^a,b   Brown, William J ^b,c  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DETROIT MEDICAL CENTER   (United States)

Author keywords

Children; Susceptibility; Yersinia enterocolitica

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; METRONIDAZOLE; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TICARCILLIN; TIMENTIN; TOBRAMYCIN;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CHILD; DILUTION; DRUG EFFICACY; FEMALE; GASTROENTERITIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; UNITED STATES; YERSINIA ENTEROCOLITICA; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEWBORN; PRESCHOOL CHILD; YERSINIOSIS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 33646162442     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.12.008     Document Type: Article

References (21)

1. Bottone E.J. Yersinia enterocolitica: a panoramic view of a charismatic microorganism. CRC Crit Rev Microbiol 5 (1977) 211-241
2. Cover T.L., and Aber R.C. Yersinia enterocolitica. N Engl J Med 321 (1989) 16-24
3. Hoogkamp-Korstanje J.A., and Stolk-Engelaar V.M. Yersinia enterocolitica infection in children. Pediatr Infect Dis J 14 (1995) 771-775
4. Marks M.I., Pai C.H., Lafleur L., Lackman L., and Hammerberg O. Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features. J Pediatr 96 (1980) 26-31
5. Abdel-Haq N.M., Asmar B.I., Abuhammour W.M., and Brown W.J. Yersinia enterocolitica infection in children. Pediatr Infect Dis J 19 (2000) 954-958
6. Lee L.A., Taylor J., Carter G.P., Quinn III B., Farmer J.J., and Tauxe R.V. Yersinia enterocolitica O:3: an emerging cause of pediatric gastroenteritis in the United States. The Yersinia enterocolitica Collaborative Study Group. J Infect Dis 163 (1991) 660-663
7. Hornstein M.J., Jupeau A.M., Scavizzi M.R., Philippon A.M., and Grimont P.A. In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics. Antimicrob Agents Chemother 27 (1985) 806-811
8. Kwaga J., and Iversen J.O. In vitro antimicrobial susceptibilities of Yersinia enterocolitica and related species isolated from slaughtered pigs and pork products. Antimicrob Agents Chemother 34 (1990) 2423-2425
9. Pham J.N., Bell S.M., Hardy M.J., Martin L., Guiyoule A., and Carniel E. Susceptibility to beta-lactam agents of Yersinia enterocolitica biotype 4, serotype O3 isolated in various parts of the world. J Med Microbiol 43 (1995) 9-13
10. Pham J.N., Bell S.M., Martin L., and Carniel E. The beta-lactamases and beta-lactam antibiotic susceptibility of Yersinia enterocolitica. J Antimicrob Chemother 46 (2000) 951-957
11. Preston M.A., Brown S., Borczyk A.A., Riley G., and Krishnan C. Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990. Antimicrob Agents Chemother 38 (1994) 2121-2124
12. Rastawicki W., Gierczynski R., Jagielski M., Kaluzewski S., and Jeljaszewicz J. Susceptibility of Polish clinical strains of Yersinia enterocolitica serotype O3 to antibiotics. Int J Antimicrob Agents 13 (2000) 297-300
13. Scribner R.K., Marks M.I., Weber A., and Pai C.H. Yersinia enterocolitica: comparative in vitro activities of seven new beta-lactam antibiotics. Antimicrob Agents Chemother 22 (1982) 40-41
14. Stolk-Engelaar V.M., Meis J.F., Mulder J.A., Loeffen F.L., and Hoogkamp-Korstanje J.A. In vitro antimicrobial susceptibility of Yersinia enterocolitica isolates from stools of patients in The Netherlands from 1982-1991. J Antimicrob Chemother 36 (1995) 839-843
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Fourteenth Informational Supplement; M100-S14 (2004), NCCLS, Wayne, PA
16. Cornelis G., and Abraham E.P. Beta-lactamases from Yersinia enterocolitica. J Gen Microbiol 87 (1975) 273-284
17. Trallero E.P., Zigorraga C., Cilla G., Idigoras P., Lopategui C.L., and Solaun L. Animal origin of the antibiotic resistance of human pathogenic Yersinia enterocolitica. Scand J Infect Dis 20 (1988) 573
18. Pai C.H., Gillis F., Tuomanen E., and Marks M.I. Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis. J Pediatr 104 (1984) 308-311
19. Hyams J.S., Durbin W.A., Grand R.J., and Goldmann D.A. Salmonella bacteremia in the first year of life. J Pediatr 96 (1980) 57-59
20. Blei F., and Puder D.R. Yersinia enterocolitica bacteremia in a chronically transfused patient with sickle cell anemia. Case report and review of the literature. Am J Pediatr Hematol Oncol 15 (1993) 430-434
21. Hoogkamp-Korstanje J.A. The possible role of quinolones in yersiniosis. Drugs 34 Suppl. 1 (1987) 134-138